Assenagon Asset Management S.A.
Position in TARS — Tarsus Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in TARS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$59,635,335
-$30,170,274 QoQ
Shares Held
947,495
-26.0% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#15
of 254 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. TARS ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
This page
|
947,495 | $59,635,335 |
All Filings in TARS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,635,335 | 947,495 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $89,805,609 | 1,280,194 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $92,338,532 | 1,127,730 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $74,165,906 | 1,247,954 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $40,412,249 | 997,587 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $57,806,917 | 1,125,305 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $63,498,980 | 1,146,812 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $37,535,613 | 1,141,247 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $28,903,809 | 1,063,422 | Shares | Sole | 2024-07-18 | |
| 2023-06-30 | $2,641,725 | 146,194 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,837,658 | 146,194 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $2,685,829 | 183,208 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,465,516 | 202,425 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $5,281,418 | 361,741 | Shares | Sole | 2022-07-27 | |
| No filing history on record for this holder in this stock. | ||||||